BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  Bristol-Myers Squibb To Announce Results For Third Quarter 2017 On October 26

  September 7, 2017

   · 

  1 min read
• Bio NC

  vTv Therapeutics Presents Further Dose Response Analysis From Phase II Study Of Its GLP-1 Receptor Agonist At 53rd Annual Meeting Of The European Association For The Study Of Diabetes

  September 7, 2017

   · 

  3 min read
• Business

  Project ALS And Amylyx Enter Collaboration To Test AMX0035

  September 7, 2017

   · 

  4 min read
• Genetown

  Cambridge’s WuXi NextCODE Completes a Whopping $240 Million Funding Round

  September 7, 2017

   · 

  3 min read
• Business

  San Diego Biotech Startup Vividion Therapeutics Names A CEO

  September 7, 2017

   · 

  3 min read
• Deals

  Biotech Pioneer BIOLIFE4D Submits Regulation A+ Filing With SEC For Up To $50 Million Initial Public Offering

  September 7, 2017

   · 

  3 min read
• BioCapital

  MakroCare At RAPS Regulatory Convergence, 9-12 September 2017, National Harbor, MD

  September 7, 2017

   · 

  1 min read
• Drug Development

  MiMedx Notified By FDA That It Can Proceed With Phase III Investigational New Drug Clinical Trial For Achilles Tendonitis

  September 7, 2017

   · 

  4 min read
• Drug Development

  Nektar Presents Clinical Data From Phase III SUMMIT-07 Study Of NKTR-181, A First-In-Class Investigational Opioid To Treat Chronic Pain, At 2017 PAINWeek

  September 7, 2017

   · 

  9 min read
• Drug Development

  AbbVie’s Upadacitinib (ABT-494) Meets Primary Endpoint In Phase IIb Study In Atopic Dermatitis

  September 7, 2017

   · 

  10 min read